Figure 9.

Evaluation of the Athletic Patient Convalesced From COVID-19 and Guidance on RTP and/or Intense Training

∗CDC Guidelines: COVID-19 Quarantine and Isolation.²⁴⁰ †Cardiopulmonary symptoms include chest pain/tightness, dyspnea, palpitations, and lightheadedness/syncope; this also includes symptoms occurring ≤1 week following COVID-19 mRNA vaccination. ‡Strategies to minimize transmission of SARS-CoV-2 to other athletes 3-10 days following a positive COVID-19 test include 1) training in isolation, 2) participating in socially-distanced outdoor training, 3) training with a face mask in a well-ventilated facility with appropriate social distancing, and 4) participating in group training after a single negative NAAT (eg, RT-PCR test) or 2 negative rapid antigen tests 24-48 hours apart. §Excludes prolonged, isolated anosmia/ageusia, which should not delay return to training. ‖Maximal-effort exercise testing should be deferred until myocarditis has been excluded. CDC = Centers for Disease Control and Prevention; CMR = cardiac magnetic resonance imaging; COVID-19 = novel coronavirus disease 2019, cTn = cardiac troponin; ECG = electrocardiogram; NAAT = nucleic acid amplification test, PASC = post-acute sequelae of SARS-CoV-2 infection; RTP = return to play; RT-PCR = reverse transcription polymerase chain reaction, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.